BI Prime, Biotech, pharma, Diagnostics, IPO, Health, Wall Street, inline, Dispensed,

The CEO of a $5.6 billion biotech that just had the year’s best post-IPO pop told told us how it’s partnering with Microsoft to build an enormous map of the human immune system

By

NIAID / Flickr Adaptive Biotechnologies, a biotech focused on using the body’s disease-fighting immune system to make diagnostic tests and medicines, went public on Thursday. The stock rose 95% after the IPO, making it the best post-IPO pop for any company this year. Adaptive is working to map out the immune system as part of […]

MustHaves.LA a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites.